Here’s what you should know:
1. Dr. Stanger is an associate professor of gastroenterology at the university.
2. In his new position, he will lead a multidisciplinary team as it researches ways to prevent and cure pancreatic cancer.
3. Dr. Stanger was the center’s scientific director. He is replacing founding director Robert Vonderheide, MD. Dr. Vonderheide will serve as the director of Penn Medicine’s Abramson Cancer Center.
4. Dr. Stanger earned his medical degree and PhD from Boston-based Harvard Medical School.
More articles on gastroenterology:
Takeda doubles down on R&D — 5 key notes
GI center to know: Boston Endoscopy Center
Drug designations, product launches & more — 4 GI company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
